Expression of transmembrane 4 superfamily member, CD9, is related to improved progression-free survival in patients with diffuse non-Hodgkin's lymphoma.

  • Authors:
    • J C Yau
    • L K Dabbagh
    • K S Formenti
    • R W Coupland
    • B F Burns
    • A R Shaw
  • View Affiliations

  • Published online on: November 1, 1998     https://doi.org/10.3892/or.5.6.1507
  • Pages: 1507-1518
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Decreased expression of the transmembrane 4 superfamily member, CD9, is associated with poor prognosis in patients with breast or non-small cell lung cancer. The expression of CD9 in lymphoma was examined in this study. Fifty-one sections with diffuse lymphomas were examined. Thirty-seven had low expression and 14 high expression of CD9. At 5 years the progression-free survival rates were 83.3+/-10.8% and 32.8+/-9.2% (p=0.018), and the actual survival were 83.3+/-10.8% and 56.8+/-8.9% (p=0.256) for those with high and low CD9 expression respectively. Decreased expression of CD9 appears to be a prognostic factor for poor survival in patients with diffuse lymphomas.

Related Articles

Journal Cover

Nov-Dec 1998
Volume 5 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yau J, Dabbagh L, Formenti K, Coupland R, Burns B and Shaw A: Expression of transmembrane 4 superfamily member, CD9, is related to improved progression-free survival in patients with diffuse non-Hodgkin's lymphoma.. Oncol Rep 5: 1507-1518, 1998
APA
Yau, J., Dabbagh, L., Formenti, K., Coupland, R., Burns, B., & Shaw, A. (1998). Expression of transmembrane 4 superfamily member, CD9, is related to improved progression-free survival in patients with diffuse non-Hodgkin's lymphoma.. Oncology Reports, 5, 1507-1518. https://doi.org/10.3892/or.5.6.1507
MLA
Yau, J., Dabbagh, L., Formenti, K., Coupland, R., Burns, B., Shaw, A."Expression of transmembrane 4 superfamily member, CD9, is related to improved progression-free survival in patients with diffuse non-Hodgkin's lymphoma.". Oncology Reports 5.6 (1998): 1507-1518.
Chicago
Yau, J., Dabbagh, L., Formenti, K., Coupland, R., Burns, B., Shaw, A."Expression of transmembrane 4 superfamily member, CD9, is related to improved progression-free survival in patients with diffuse non-Hodgkin's lymphoma.". Oncology Reports 5, no. 6 (1998): 1507-1518. https://doi.org/10.3892/or.5.6.1507